Acelyrin unveils phase 3 program design for lonigutamab in thyroid eye disease
The company also released additional data from its phase 2 clinical trial in addition to the LONGITUDE program design.
The company also released additional data from its phase 2 clinical trial in addition to the LONGITUDE program design.
randomized, paired-eye study. Methods: Patients with bilateral cataracts and coexisting regular corneal astigmatism were enrolled. The 2 eyes of each patient were randomly assigned to…
Objective Retinopathy of prematurity (ROP) is a leading cause of preventable childhood blindness in preterm infants with low birth weight. The efficacy and safety of…
The primary safety endpoint was carried out through the percentage of patients with shift from normal (at baseline) to abnormal in any electrocardiogram (ECG).
Prevent Blindness joins efforts in January for National Glaucoma Awareness Month to provide patients, care partners, and professionals with free educational
Four ophthalmologists discuss challenges, offer guidance to colleagues whose patients are losing their vision.
Get insights into the main causes of glaucoma and the types of glaucoma. Understand the impact of glaucoma on your eye’s optic nerve. Learn how…
halmic services between November 2018 and October 2023. Results: Of 392 patients identified, 59 eyes (10.5%) of 41 patients were included. Laser was administered in…
The rationale was that commercial mydriatics administered during retinopathy of prematurity (ROP) screening have been associated with cardiorespiratory and gastrointestinal adverse events.
Read articles appearing in the print edition of Ocular Surgery News U.S. Edition. Healio is your trusted source for medical news.
NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: Advancing Vision Health Equity through Multi-level Interventions and Community-Engaged Research (R01 –…